Literature DB >> 33987128

Coombs-Negative Haemolytic Anaemia, Direct Hyperbilirubinaemia and Splenomegaly: A Rare Amalgam.

Radhika Kulkarni1, Amjad Basheer1, Aziz Khan1.   

Abstract

INTRODUCTION: Epstein-Barr virus (EBV) is notorious for its varied presentation in adults. Reactivation of EBV can occur at any time and is often due to weakened cellular immunity. CASE DESCRIPTION: Here we report the case of a young woman with no previous medical history who presented with cholestatic hepatitis, Coombs-negative haemolytic anaemia and splenomegaly. Due to the initial disjointed picture with no other localizing symptoms, she underwent extensive work-up for the same. DISCUSSION: EBV has been associated with many malignancies, autoimmune diseases and chronic fatigue syndrome. EBV causes elevated liver enzymes; however, cholestatic hepatitis is exceedingly rare, with only a few cases reported. Haemolytic anaemia is a common complication of EBV infection and is often Coombs positive.
CONCLUSION: EBV testing should be considered before more invasive and expensive work-up in a patient presenting with multi-systemic abnormalities. LEARNING POINTS: Epstein-Barr virus (EBV) can have myriad manifestations in all age groups.Coombs-negative haemolytic anaemia can occur as a complication of EBV.EBV testing should be considered prior to more expensive work-up in anyone presenting with abnormalities in the reticuloendothelial system. © EFIM 2021.

Entities:  

Keywords:  Herpesvirus 4; cholestasis; direct Coombs test; splenomegaly

Year:  2021        PMID: 33987128      PMCID: PMC8112081          DOI: 10.12890/2021_002477

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

1.  Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia.

Authors:  Toyomi Kamesaki; Takashi Oyamada; Mitsuhiro Omine; Keiya Ozawa; Eiji Kajii
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

2.  Severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly.

Authors:  Y Edoute; Y Baruch; J Lachter; E Furman; L Bassan; N Assy
Journal:  J Gastroenterol Hepatol       Date:  1998-08       Impact factor: 4.029

Review 3.  Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors.

Authors:  Jonathan R Kerr
Journal:  J Clin Pathol       Date:  2019-07-17       Impact factor: 3.411

Review 4.  Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature.

Authors:  A P Feranchak; R W Tyson; M R Narkewicz; F M Karrer; R J Sokol
Journal:  Liver Transpl Surg       Date:  1998-11

5.  A Rare Presentation of Epstein-Barr Virus Infection.

Authors:  John Teijido; Kelly Tillotson; J Marc Liu
Journal:  J Emerg Med       Date:  2020-01-20       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.